GLP-1 Telehealth: What Prescribers Need to Know

You’ve probably noticed: your patients keep asking about Ozempic. Some gained 40 pounds on their antipsychotic. Others saw a friend lose weight on semaglutide and want to know if you prescribe it. Maybe you’ve even had a few patients stop their psych meds because the weight gain became unbearable.

Here’s what most psychiatrists don’t realize: you’re already positioned to capture a massive, underserved market in weight management — and you can do it without adding unsustainable workload to your practice.

The numbers tell the story. By 2024, roughly 4% of Americans were on GLP-1 medications, half of them for weight loss — a 600% increase in obesity usage over six years. By late 2025, that jumped to an estimated 6% (20 million Americans) actively taking GLP-1 drugs. Meanwhile, a late-2023 survey found nearly half of psychiatrists were already prescribing or recommending these medications.

The patient demand is real. The revenue opportunity is substantial. But here’s the catch: scaling a GLP-1 practice the wrong way will eat your schedule alive and leave you answering medication titration questions at 10 PM.

This guide shows you how to build a profitable GLP-1 weight-loss service line as a psychiatrist — with sustainable workflows, clear economics, and strategies that prevent burnout before it starts.

Why Psychiatrists Have a Natural Advantage in GLP-1 Care

You Already Understand the Mind-Body Connection

Weight loss isn’t just pharmacology — it’s psychology, behavior change, and emotional resilience. As a psychiatrist, you already help patients navigate complex behavioral patterns and manage motivation over months or years. That’s exactly what successful GLP-1 therapy requires.

Many weight-loss clinics treat obesity as a purely metabolic problem. They prescribe the drug, track the scale, and move on. But patients who lose 50 pounds face identity shifts, social pressures, and sometimes unexpected mood changes. Who’s better equipped to navigate those conversations than a mental health provider?

Your Existing Patient Base Needs This

Psychiatric medications cause weight gain. Full stop. Atypical antipsychotics, mood stabilizers, mirtazapine — your patients live with this daily frustration. Some stop their meds rather than gain more weight, risking relapse. Others slide into metabolic syndrome, adding diabetes and hypertension to their chart.

By integrating GLP-1 treatment into your psychiatric practice, you’re not adding a random service line — you’re addressing a core treatment side effect your patients already complain about. This isn’t a hard pivot; it’s a natural extension of comprehensive psychiatric care.

The Market Has Supply-Demand Imbalance

Here’s the reality: tens of thousands of new patients start GLP-1 treatments each week, but there aren’t nearly enough obesity medicine specialists to handle the volume. Many primary care physicians don’t have the time or interest to manage long-term weight therapy. Endocrinologists are swamped with diabetes patients.

This creates a massive gap — and psychiatrists who step in can build robust practices quickly. You’re not competing with entrenched specialists; you’re filling a void.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Business Model: Cash-Pay vs Insurance

Let’s talk money, because this determines whether your GLP-1 practice becomes profitable or a reimbursement nightmare.

Why Most Weight-Loss Telehealth Practices Favor Cash-Pay

Insurance coverage for GLP-1 obesity treatment remains limited. While most insurers cover these medications for diabetes, obesity coverage is rare. As of mid-2024, only 13 state Medicaid programs (including California and Pennsylvania) covered GLP-1s for weight loss. Many private plans explicitly exclude them.

What this means practically: most patients expect to pay out-of-pocket for the medication anyway. Monthly costs vary widely — brand-name Wegovy can run $1,300+ without insurance, while compounded semaglutide from reputable pharmacies might cost $200-400.

Since patients are already writing checks for medication, they’re often willing to pay cash for the clinical visits too. This creates a cleaner business model:

• Transparent pricing — patients know upfront what visits cost
• No prior authorization battles for your time (though they may still fight with insurance over meds)
• Faster revenue cycle — no waiting 60-90 days for claims processing
• Less documentation burden — you’re not justifying medical necessity to insurance reviewers

Many successful GLP-1 practices charge either:

• Per-visit fees ($150-300 for initial consult, $75-150 for follow-ups), or
• Monthly subscription packages ($99-299/month including consultations, check-ins, and sometimes medication coordination)

When Insurance Billing Makes Sense

That said, accepting insurance for visits can expand your patient pool — particularly for those who can only afford treatment if visits are covered. You could bill standard E/M codes or Medicare’s G0447 code for obesity counseling.

The trade-offs:

• More patients — removes financial barrier for consultations
• Credibility — some patients prefer in-network providers
• Administrative overhead — extensive documentation, potential denials, coordination with pharmacies on prior authorizations

A hybrid approach works well: charge cash for the comprehensive initial evaluation (which often isn’t fully reimbursed anyway), but accept insurance for follow-up visits if patients have good coverage. Just be transparent about what’s cash vs. billed.

One encouraging trend: Medicare announced plans in late 2025 to pilot covering weight-loss drugs. If that policy expands, insurance-based models may become more viable long-term.

How to Actually Get GLP-1 Patients

Here’s where theory meets practice. You need a patient acquisition strategy that doesn’t require you to become a marketing expert or burn through thousands of dollars testing Google Ads.

Start with Your Current Patients

The easiest first step: identify patients in your existing caseload who meet criteria (BMI ≥30, or ≥27 with weight-related comorbidities like hypertension or prediabetes).

During medication management visits, bring it up naturally:

‘I know you mentioned frustration about weight gain on the Seroquel. Have you heard about GLP-1 medications like semaglutide? I’ve started helping some patients manage weight medically — would you like to discuss whether that might be appropriate for you?’

This ‘no additional marketing’ approach converts existing patients into GLP-1 clients. You’re leveraging trust you’ve already built and addressing a real pain point. Many will say yes immediately.

Join a Telehealth Platform That Handles Patient Acquisition

Here’s the truth about DIY marketing: acquiring a qualified psychiatric patient through independent marketing typically costs $200-500+ when you factor in all costs — agency fees, ad spend, staff time to qualify leads, no-show rates, months of SEO investment before results, and failed campaigns.

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.
• Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert. Realistic cost per booked patient through PPC: $200-400+.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers on the same page.

This is where platforms like Klarity Health make economic sense. Instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you.

Klarity’s model:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

That’s guaranteed ROI vs. rolling the dice on marketing channels you may not have time to optimize.

Build Referral Relationships

Primary care physicians, endocrinologists, and therapists all encounter patients who need weight management but lack bandwidth to provide it. Send brief introductory emails:

‘Hi Dr. [Name], I’m a psychiatrist in [area] who’s now offering medical weight management including GLP-1 therapies. I work with patients who need psychiatric medication but struggle with weight gain, and I’m happy to co-manage or consult on complex cases. I’ll always keep you updated and refer patients back for routine care.’

Mental health therapists are particularly good referral sources — they see clients whose weight loss stalls due to emotional eating, trauma, or lack of motivation. They’ll gladly refer for medication support.

State-Specific Licensing and Scope of Practice: What You Need to Know

Rule #1: You must be licensed in the patient’s state. Unlike controlled substances (which trigger federal Ryan Haight requirements), GLP-1 medications are not scheduled drugs — meaning you can legally prescribe them via telehealth across state lines if you’re licensed in that state.

For Psychiatrists (MD/DO)

You have full prescriptive authority everywhere. Key considerations:

California:

• Requires full CA license (not in Interstate Medical Licensure Compact)
• Must obtain verbal or written patient consent for telehealth
• No in-person exam requirement for non-controlled substances

Texas:

• Joined IMLC (expedited licensing available)
• Audio-video required for evaluations (audio-only only for mental health services)
• Can establish patient relationship entirely via synchronous telehealth — no in-person visit needed

Florida:

• Offers Out-of-State Telehealth Provider Registration for physicians (easier than full licensure)
• Can prescribe GLP-1s to Florida patients with this registration (controlled substance restrictions don’t apply to semaglutide)
• No mandatory in-person exam for telehealth

New York:

• Requires full NY license (not in IMLC)
• Strong telehealth parity law (insurers must cover like in-person)
• No special teleprescribing restrictions

Pennsylvania:

• IMLC member (expedited licensing)
• Video consult sufficient to establish care
• Joined Nurse Licensure Compact in 2025 (eases some multi-state practice)

Illinois:

• IMLC member
• Comprehensive 2021 telehealth parity law
• Allows telehealth as means to establish patient relationship

For Psychiatric Nurse Practitioners (PMHNPs)

Your scope varies significantly by state. Most require physician collaboration for prescribing, with some exceptions:

California:

• As of 2026, experienced NPs can become fully independent ‘104 NPs’ after 3 years in supervised ‘103 NP’ status
• Until then, need physician-supervised protocols

Texas:

• Strict supervision — must have Prescriptive Authority Agreement with TX physician
• One MD can supervise up to 7 NPs/PAs

Florida:

• Psychiatric NPs do NOT qualify for autonomous practice (limited to primary care NPs)
• Must maintain physician collaboration agreement

New York:

• Independent practice after 3,600 hours (≈2 years) under collaboration
• PMHNPs meeting this threshold can prescribe independently

Pennsylvania:

• No independent practice — all NPs require physician Collaborative Agreement
• Multiple bills for independence have stalled

Illinois:

• Can achieve Full Practice Authority after 4,000 hours of clinical practice plus 250 hours additional education
• FPA eliminates physician oversight requirement

Building Workflows That Scale Without Destroying Your Life

Here’s where most providers fail: they add GLP-1 patients to their existing schedule with no workflow optimization, then wonder why they’re drowning in medication questions and side effect calls.

Create a Streamlined Intake Process

Before the first appointment:

• Digital intake forms gather comprehensive history (weight timeline, diet patterns, medical conditions, psychiatric history, binge eating screening)
• Pre-visit lab orders (A1c, fasting glucose, TSH, liver panel) — patients get labs done locally before consult
• Standardized inclusion/exclusion criteria (so staff can pre-screen inappropriate referrals)

This saves 10-15 minutes per initial consult and ensures you’re not missing contraindications or key behavioral health factors.

Develop Clinical Protocols and Templates

Create an ‘Obesity Intake Panel’ in your EHR that orders all necessary labs with one click. Build encounter templates that prompt you to cover:

• Nutrition and exercise assessment
• Realistic goal-setting (1-2 lbs/week is healthy)
• Medication teaching (injection technique, side effect management)
• Mental health screening (especially for binge eating disorder)
• Informed consent for off-label use (if using Ozempic instead of Wegovy)

Clinical checklists ensure consistency even as your volume grows. You’re not reinventing the wheel each visit.

Right-Size Your Follow-Up Schedule

During the first 3-6 months of GLP-1 therapy, patients typically need monthly follow-ups for dose titration and side effect management. But these don’t all need to be with you.

Team-based care model:

• Month 1 and 3: Provider visit (psychiatrist or PMHNP) for medication adjustment
• Month 2 and 4: Health coach or RN check-in (weight, blood pressure, symptom questionnaire)
• Ongoing: Dietitian referrals for nutrition counseling, monthly support groups for motivation

Once patients stabilize on their dose, you can space visits to every 2-3 months with brief virtual check-ins between.

Leverage Technology

Remote patient monitoring tools:

• Connected scales that auto-report weights to your EHR
• Symptom tracking apps where patients log side effects
• Automated appointment reminders and med refill notifications

This lets you track progress at a glance rather than spending visit time collecting data. Many platforms can graph weight trends and medication adherence, which you review in 30 seconds instead of 5 minutes of questions.

Asynchronous communication:

• Portal messaging with templated responses for common questions
• FAQ page or chatbot for ‘Is nausea normal?’ type questions
• Video libraries where you pre-record injection technique demonstrations

Delegate Everything Non-Specialist

Medical assistants or RNs can:

• Gather interim data (weights, BP, symptom questionnaires) before visits
• Handle routine patient questions via portal messaging
• Coordinate lab orders and pharmacy communications
• Schedule follow-ups and track no-shows

Health coaches or dietitians can:

• Provide behavioral counseling on nutrition and exercise
• Lead group support sessions
• Follow up on lifestyle adherence

You focus on medication decisions, managing complex cases, and addressing mental health factors. Everything else gets delegated.

The Mental Health Angle: Your Unique Value Proposition

Unlike primary care doctors or obesity specialists, you bring psychiatric expertise. Use it as your differentiator.

Screen for Mental Health Barriers

Binge eating disorder, emotional overeating, depression, and anxiety frequently sabotage weight loss efforts. During intake, explicitly screen:

• ‘Do you ever feel loss of control around eating?’
• ‘Have you noticed mood changes affecting your appetite?’
• ‘How has your weight affected your self-esteem or social life?’

Identifying these patterns upfront lets you provide targeted support — or decide GLP-1 therapy might not be appropriate until underlying psychiatric issues are addressed.

Monitor for GLP-1 Mood Effects

There were reports in 2023 of rare suicidal ideation possibly linked to GLP-1s. By early 2026, the FDA reviewed data and found no clear causal link, even directing removal of suicide warnings from labels. Still, you should monitor mood more carefully than other providers would:

• Include depression screening (PHQ-9) at baseline and follow-ups
• Ask explicitly: ‘Have you noticed any changes in your mood, anxiety, or sleep since starting this medication?’
• Document your assessment in every note

This isn’t just good medicine — it’s marketing. When you tell prospective patients ‘I’m a psychiatrist who specializes in medical weight management, so I monitor both your physical and mental health throughout treatment,’ you stand out from generic telehealth weight-loss mills.

Position Yourself as the Whole-Person Provider

Many patients want integrated care — someone who treats their depression AND helps with weight gain from antidepressants. Frame your service that way:

‘I help patients optimize both their mental health and metabolic health. If your psychiatric medication is causing weight gain, we can address that medically while maintaining your mood stability.’

This attracts patients who value comprehensive treatment over fragmented care.

Preventing Burnout: Set Boundaries Before You Need Them

The demand for GLP-1 care can be overwhelming. Protect yourself proactively.

Calibrate Patient Load Gradually

Don’t go from zero to 50 weight-loss patients overnight. Start with:

• One half-day per week dedicated to GLP-1 consultations
• Cap new intakes (e.g., 5 new patients/week) until you refine workflows
• Build support structures first (hire or contract with health coach, finalize protocols)

Once you’re confident, scale up.

Maintain Practice Variety (If Desired)

Some psychiatrists fully transition to obesity medicine. Others prefer keeping a mix of psychiatric and weight-management patients for variety. Either is fine — just be intentional.

If you want balance:

• Block schedule (e.g., Monday/Wednesday psych patients, Tuesday/Thursday weight-loss)
• Or alternate weeks
• Or keep a 70/30 split long-term

Protect Your Personal Time

Telehealth’s flexibility is a double-edged sword. Set firm boundaries:

• Defined availability hours for patient messages (e.g., no portal responses after 6 PM)
• Use auto-responders outside business hours
• Schedule regular time off and actually take it

Evidence shows greater schedule control and virtual practice options mitigate provider burnout. You’re building this practice — design it to be sustainable from day one.

Join Communities of Practice

Connect with other providers doing GLP-1 work:

• Obesity medicine interest groups
• Telehealth clinician forums
• Psychiatric prescriber networks

You’ll learn workflow hacks, get emotional support, and avoid reinventing solutions to common problems.

Consider Hiring Help or Partnering

As you scale, you might:

• Hire a part-time PMHNP or PA to handle routine follow-ups (with you supervising)
• Partner with another psychiatrist to share the GLP-1 caseload
• Contract with established obesity medicine specialists for complex cases

Team-based care isn’t just good for patients — it prevents you from becoming the bottleneck.

Key Compliance Points

Standard of Care

Treat GLP-1 prescribing with the same rigor as any medical treatment:

• Thorough history and physical assessment (can be via video)
• Document baseline BMI, weight, comorbidities
• Review contraindications (history of medullary thyroid cancer, pancreatitis, severe GI disease)
• Obtain informed consent for off-label use if applicable
• Order and review appropriate labs
• Create treatment plan including lifestyle modification
• Schedule regular follow-ups

Medication Sourcing

Be cautious with compounded semaglutide. The FDA has warned about unregulated suppliers. If using compounding pharmacies:

• Verify they’re licensed and use FDA-compliant ingredients
• Document your due diligence
• Educate patients about the difference between brand-name and compounded

Many providers stick to FDA-approved formulations (Wegovy, Saxenda, Zepbound) to avoid liability gray areas.

Malpractice Insurance

Inform your insurer you’re prescribing weight-loss medications. Some policies require notification for services outside your primary specialty. Better to clarify upfront than face a coverage denial after a claim.

Documentation

Every encounter must document:

• Current weight and BMI
• Side effects or complications
• Dose adjustments and rationale
• Lifestyle counseling provided
• Patient’s progress toward goals
• Plan for next visit

Good documentation protects you legally and supports quality care.

Real Talk: The Economics of This Practice Model

Let’s run realistic numbers. Assume you dedicate one half-day per week to GLP-1 consultations:

Initial consults:

• 3 new patients/week × $250/consult = $750/week
• That’s $3,000/month in new patient revenue alone

Follow-ups:

• After 3 months, you have ~36 active GLP-1 patients
• Monthly follow-up rate: 50% (some see you monthly, others every 2-3 months) = 18 visits/month
• $100/follow-up × 18 = $1,800/month

Total monthly revenue from one half-day per week: ~$4,800

Now scale that to two half-days per week, or add a PMHNP seeing patients under your supervision. You can see how this grows quickly.

Compare that to traditional psychiatric billing where you might see 4-5 medication management patients per half-day at $150-200 each = $600-1,000 per half-day. GLP-1 consultations are often more lucrative per time unit, especially in cash-pay models.

And remember: this isn’t spending $3,000-5,000/month on marketing with no guarantee of results. If you’re using a platform like Klarity, you’re paying a per-appointment fee only when qualified patients book — the acquisition cost is built into each visit, not coming out of your pocket upfront.

Your Next Steps

1. Get licensed in your target states if you’re not already
2. Join a telehealth platform that handles patient acquisition (or start marketing independently if you have the bandwidth)
3. Create your intake and follow-up protocols now, before your first patient
4. Order business cards or update your website with new service line
5. Tell your current patients you’re offering this — you’ll be surprised how many say ‘I’ve been wanting to ask about that’
6. Start with 2-3 patients and refine your workflow
7. Scale gradually as you get comfortable

The GLP-1 weight-loss market is booming, and psychiatrists are uniquely positioned to capture it. You bring medical expertise, behavioral health training, and existing patient relationships. You can build a practice that’s financially rewarding, professionally satisfying, and — most importantly — sustainable.

The providers who will thrive are those who build smart systems, set clear boundaries, and leverage platforms that remove the marketing risk. Start small, scale thoughtfully, and don’t burn yourself out chasing every patient inquiry.

Your patients are already asking for this. The demand is there. Now you know how to meet it without sacrificing your well-being.

Frequently Asked Questions

Can I prescribe GLP-1 medications via telehealth legally?

Yes. GLP-1 medications like semaglutide are not controlled substances, so the Ryan Haight Act’s in-person exam requirement doesn’t apply. As long as you’re licensed in the patient’s state and conduct an appropriate telehealth evaluation, you can prescribe these medications remotely.

Do I need special training or certification in obesity medicine?

Not legally required, but highly recommended for quality care and professional confidence. Consider CME courses in obesity medicine or bariatric pharmacology. The Obesity Medicine Association offers certificate programs. This training helps you manage complex cases and feel competent advising on nutrition and lifestyle — reducing anxiety about practicing outside your primary specialty.

What if a patient has side effects I’m not comfortable managing?

Have a referral network. Establish relationships with gastroenterologists (for severe GI issues), endocrinologists (for complex metabolic concerns), and primary care physicians. You should manage common side effects (nausea, constipation, injection site reactions), but know when to escalate. Part of standard care is recognizing your limits.

How do I handle prior authorizations for the medications?

If patients are trying to use insurance for meds, prior authorization falls on the pharmacy or patient (unless you’ve agreed to handle it). Many cash-pay practices avoid this by directing patients to compounding pharmacies or using medication discount programs. If you do assist with PAs, delegate this to staff with templated letters of medical necessity.

What about liability if a patient doesn’t lose weight or regains it?

Set realistic expectations upfront. GLP-1s are tools, not guarantees. Document that you discussed: expected weight loss timelines (1-2 lbs/week, 10-15% total body weight over 6-12 months), the need for lifestyle changes, and that individual results vary. Weight regain after stopping medication is common and should be addressed in informed consent. Your job is to provide appropriate medical care, not guarantee specific outcomes.

Can I prescribe GLP-1s to patients who don’t meet BMI criteria but want to lose ‘vanity weight’?

Ethically murky. FDA approval is for BMI ≥30 or ≥27 with comorbidities. Prescribing outside these parameters is off-label and may not be medically justified. Some providers do it in cash-pay models, but you’re taking on liability. Better approach: stick to evidence-based criteria and focus on health improvement, not cosmetic weight loss.

Citations

1. Axios (May 27, 2025). ‘Just how many Americans are taking GLP-1s now’ – Fair Health data analysis showing 600% increase in GLP-1 weight-loss usage and 4% of Americans using these medications by 2024. https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews (October 20, 2025). ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ – Reports estimated 6% (20 million) Americans actively taking GLP-1 drugs by late 2025, with nearly 75% of Americans overweight or obese. https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Schizophrenia.com Forum (November 6, 2023). ‘Psychiatrists recommend Ozempic’ – Survey finding nearly half of psychiatrists across major psychiatric departments were prescribing or recommending Ozempic or similar weight-loss drugs. https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318

4. MedicalDirectorCo (2025). ‘Texas Weight Loss Clinic & Telehealth Compliance Guide’ – Comprehensive compliance guidance confirming GLP-1 medications are not controlled substances and can be prescribed via telehealth, with Texas-specific regulatory details. https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/

5. Axios (November 5, 2024). ‘States slow to cover GLP-1s for weight loss’ – Kaiser Family Foundation analysis showing only 13 state Medicaid programs covered GLP-1s for weight loss as of mid-2024, with most insurers limiting coverage to diabetes. https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is